Putnam Investments’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$3.2M	Buy	102,262 +16,859	+20%	+$403K	﹤0.01%	623
2023 Q3	$1.78M	Buy	85,403 +4,923	+6%	+$134K	﹤0.01%	746
2023 Q2	$1.93M	Buy	80,480 +55,157	+218%	+$1.23M	﹤0.01%	738
2023 Q1	$477K	Sell	25,323 -1,067	-4%	-$20.3K	﹤0.01%	949
2022 Q4	$420K	Sell	26,390 -14	-0.1%	-$219	﹤0.01%	974
2022 Q3	$432K	Buy	+26,404	New	+$428K	﹤0.01%	966
2020 Q3	–	Sell	-74,844	Closed	-$3.63M	–	823
2020 Q2	$3.63M	Buy	74,844 +5,132	+7%	+$246K	0.01%	521
2020 Q1	$2.94M	Buy	69,712 +6,541	+10%	+$270K	0.01%	533
2019 Q4	$2.7M	Buy	+63,171	New	+$2.75M	0.01%	687
2017 Q2	–	Sell	-13,178	Closed	-$454K	–	1101
2017 Q1	$454K	Sell	13,178 -3,469	-21%	-$122K	﹤0.01%	1118
2016 Q4	$480K	Buy	16,647 +286	+2%	+$7.57K	﹤0.01%	1124
2016 Q3	$521K	Sell	16,361 -21,835	-57%	-$740K	﹤0.01%	1120
2016 Q2	$1.24M	Sell	38,196 -41,110	-52%	-$1.38M	﹤0.01%	1065
2016 Q1	$2.22M	Buy	79,306 +13,548	+21%	+$295K	0.01%	921
2015 Q4	$2.34M	Sell	65,758 -1,523	-2%	-$53.7K	0.01%	933
2015 Q3	$2.23M	Buy	67,281 +2,039	+3%	+$84.8K	0.01%	964
2015 Q2	$2.73M	Sell	65,242 -484	-0.7%	-$18.7K	0.01%	959
2015 Q1	$2.14M	Sell	65,726 -2,451	-4%	-$84.2K	﹤0.01%	1038
2014 Q4	$2.16M	Sell	68,177 -380	-0.6%	-$10.8K	﹤0.01%	1004
2014 Q3	$1.7M	Buy	68,557 +1,277	+2%	+$29.9K	﹤0.01%	1067
2014 Q2	$1.52M	Buy	67,280 +87	+0.1%	+$1.82K	﹤0.01%	1100
2014 Q1	$1.63M	Sell	67,193 -98,171	-59%	-$2.48M	﹤0.01%	1091
2013 Q4	$4.13M	Sell	165,364 -154,929	-48%	-$3.66M	0.01%	826
2013 Q3	$8.8M	Sell	320,293 -36,707	-10%	-$767K	0.02%	475
2013 Q2	$6.48M	Buy	+357,000	New	+$4.92M	0.02%	571